QA: Nanoviricides INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2015_Nanoviricides_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 36,954,981
1 IntangibleAssetsNetIncludingGoodwill 408,258
2 PropertyPlantAndEquipmentNet 5,496,756
3 remainder_Assets 1,000,000
4 LiabilitiesCurrent 517,739
5 LiabilitiesNoncurrent 19,972,953
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,404,653
9 ResearchAndDevelopmentExpense 5,155,641
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -18,150,111
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 43,859,995
1 Liabilities 20,490,692
2 Expenses 8,560,294
3 Revenues 0
4 StockholdersEquity 23,369,303
5 NetIncome -26,710,405
6 ComprehensiveNetIncome -26,710,405
7 BaseVar 45,530,546
8 EconomicCapitalRatiobeforeLimitedLiability 0.753
9 EconomicCapitalRatio 2.10

Edgar->Model Mapping

Feature Distribution

Change over Time